Alphatec Holdings (ATEC) Change in Receivables (2010 - 2026)
Alphatec Holdings (ATEC) reported Change in Receivables of $10.2 million for Q1 2026, little changed on a YoY basis from $10.3 million in Q1 2025, and up 203.44% sequentially from $3.4 million in Q4 2025.
Alphatec Holdings (ATEC) Change in Receivables (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Change in Receivables data on file, last reported at $10.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables changed 0.43% year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $21.8 million (up 179.47% YoY), and the FY2025 full-year result was $21.9 million, up 49.97% from the prior year.
- Change in Receivables advanced to $10.2 million in Q1 2026, from $3.4 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $17.1 million in Q1 2024 to a low of -$5.8 million in Q3 2024.
- A 5-year average of $4.6 million and a median of $5.0 million in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables surged 4950.0% in 2022 and sank 215.45% in 2024, its largest moves.
- Tracing ATEC's Change in Receivables over 5 years: stood at $8.7 million in 2022, then retreated by 9.68% to $7.9 million in 2023, then tumbled by 34.96% to $5.1 million in 2024, then tumbled by 33.97% to $3.4 million in 2025, then soared by 203.44% to $10.2 million in 2026.
- Business Quant data shows ATEC's Change in Receivables at $10.2 million in Q1 2026, $3.4 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | 10.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.24 Mn |
| Mar 31, 2026 | 10.24 Mn |
| Dec 31, 2025 | 3.37 Mn |
| Dec 31, 2025 | 3.37 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 5.97 Mn |
| Jun 30, 2025 | 5.97 Mn |
| Mar 31, 2025 | 10.28 Mn |
| Mar 31, 2025 | 10.28 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Sep 30, 2024 | -5.81 Mn |
| Sep 30, 2024 | -5.81 Mn |
| Jun 30, 2024 | -1.77 Mn |
| Jun 30, 2024 | -1.77 Mn |
| Mar 31, 2024 | 17.06 Mn |
| Mar 31, 2024 | 17.06 Mn |
| Dec 31, 2023 | 7.86 Mn |
| Dec 31, 2023 | 7.86 Mn |